242 related articles for article (PubMed ID: 21034695)
1. Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.
Gao K; Kemp DE; Fein E; Wang Z; Fang Y; Ganocy SJ; Calabrese JR
J Clin Psychiatry; 2011 Aug; 72(8):1063-71. PubMed ID: 21034695
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder.
Wang Z; Kemp DE; Chan PK; Fang Y; Ganocy SJ; Calabrese JR; Gao K
Int J Neuropsychopharmacol; 2011 Feb; 14(1):131-42. PubMed ID: 20875219
[TBL] [Abstract][Full Text] [Related]
3. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Gao K; Ganocy SJ; Gajwani P; Muzina DJ; Kemp DE; Calabrese JR
J Clin Psychiatry; 2008 Feb; 69(2):302-9. PubMed ID: 18211129
[TBL] [Abstract][Full Text] [Related]
4. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
Maher AR; Theodore G
J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
[TBL] [Abstract][Full Text] [Related]
5. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
Gao K; Muzina D; Gajwani P; Calabrese JR
J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.
Gao K; Kemp DE; Ganocy SJ; Gajwani P; Xia G; Calabrese JR
J Clin Psychopharmacol; 2008 Apr; 28(2):203-9. PubMed ID: 18344731
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine: a review of its use in the management of bipolar depression.
Sanford M; Keating GM
CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
Derry S; Moore RA
BMC Psychiatry; 2007 Aug; 7():40. PubMed ID: 17705840
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
Maneeton N; Maneeton B; Srisurapanont M; Martin SD
BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
[TBL] [Abstract][Full Text] [Related]
11. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
12. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
13. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials.
Maneeton N; Maneeton B; Woottiluk P; Likhitsathian S; Suttajit S; Boonyanaruthee V; Srisurapanont M
Drug Des Devel Ther; 2016; 10():259-76. PubMed ID: 26834458
[TBL] [Abstract][Full Text] [Related]
15. Typical and atypical antipsychotics in bipolar depression.
Gao K; Gajwani P; Elhaj O; Calabrese JR
J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics for fibromyalgia in adults.
Walitt B; Klose P; Üçeyler N; Phillips T; Häuser W
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011804. PubMed ID: 27251337
[TBL] [Abstract][Full Text] [Related]
17. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.
Gao K; Ganocy SJ; Conroy C; Brownrigg B; Serrano MB; Calabrese JR
Psychopharmacology (Berl); 2017 Aug; 234(15):2233-2244. PubMed ID: 28536866
[TBL] [Abstract][Full Text] [Related]
18. Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan.
Kishi T; Yoshimura R; Sakuma K; Okuya M; Iwata N
Neuropsychopharmacol Rep; 2020 Dec; 40(4):417-422. PubMed ID: 32902200
[TBL] [Abstract][Full Text] [Related]
19. Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia.
Gao K; Pappadopulos E; Karayal ON; Kolluri S; Calabrese JR
J Clin Psychopharmacol; 2013 Jun; 33(3):425-31. PubMed ID: 23609405
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
